2018-2023 Global Irritable Bowel Syndrome (IBS) Consumption Market Report
The report requires updating with new data and is sent in 48 hours after order is placed.
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Irritable Bowel Syndrome (IBS) market for 2018-2023.
Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.
Currently, the IBS treatment market is naive and underpenetrated, with 4 products indicated for IBS in the market. These include the IBS-C therapies, Amitiza (lubiprostone, Sucampo/Takeda) and Linzess (linaclotide, Ironwood/Allergan/Astellas); and the IBS-D therapies, Lotronex (Sebela Pharmaceuticals) and Irribow (ramosetron, Astellas). Antidepressants and antibiotics (mainly Xifaxan [rifaximin], Valeant) are also used off-label to treat IBS.
The IBS treatment market is characterized by significant unmet needs, which include the need for products with improved efficacy, products for the treatment of the IBS-D and IBS-M subtypes, and products that effectively address IBS symptoms, such as abdominal pain and bloating, as well as the requirement for the improved diagnosis of IBS. As a result, there are significant opportunities in the uncrowded IBS therapeutics market.
Over the next five years, LPI(LP Information) projects that Irritable Bowel Syndrome (IBS) will register a 16.3% CAGR in terms of revenue, reach US$ 6530 million by 2023, from US$ 2640 million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Irritable Bowel Syndrome (IBS) market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Research objectives
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Irritable Bowel Syndrome (IBS) market for 2018-2023.
Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.
Currently, the IBS treatment market is naive and underpenetrated, with 4 products indicated for IBS in the market. These include the IBS-C therapies, Amitiza (lubiprostone, Sucampo/Takeda) and Linzess (linaclotide, Ironwood/Allergan/Astellas); and the IBS-D therapies, Lotronex (Sebela Pharmaceuticals) and Irribow (ramosetron, Astellas). Antidepressants and antibiotics (mainly Xifaxan [rifaximin], Valeant) are also used off-label to treat IBS.
The IBS treatment market is characterized by significant unmet needs, which include the need for products with improved efficacy, products for the treatment of the IBS-D and IBS-M subtypes, and products that effectively address IBS symptoms, such as abdominal pain and bloating, as well as the requirement for the improved diagnosis of IBS. As a result, there are significant opportunities in the uncrowded IBS therapeutics market.
Over the next five years, LPI(LP Information) projects that Irritable Bowel Syndrome (IBS) will register a 16.3% CAGR in terms of revenue, reach US$ 6530 million by 2023, from US$ 2640 million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Irritable Bowel Syndrome (IBS) market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
- IBS-D Drug
- IBS-C Drug
- Other
- Women
- Men
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Spain
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Allergan
- Valeant Pharmaceuticals
- Takeda
- Sucampo Pharmaceuticals
- McNeil Consumer Healthcare
- Sebela Pharmaceuticals
- Astellas Pharmaceuticals
- IM HealthScience
Research objectives
- To study and analyze the global Irritable Bowel Syndrome (IBS) consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
- To understand the structure of Irritable Bowel Syndrome (IBS) market by identifying its various subsegments.
- Focuses on the key global Irritable Bowel Syndrome (IBS) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the Irritable Bowel Syndrome (IBS) with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of Irritable Bowel Syndrome (IBS) submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Irritable Bowel Syndrome (IBS) Consumption 2013-2023
2.1.2 Irritable Bowel Syndrome (IBS) Consumption CAGR by Region
2.2 Irritable Bowel Syndrome (IBS) Segment by Type
2.2.1 IBS-D Drug
2.2.2 IBS-C Drug
2.2.3 Other
2.3 Irritable Bowel Syndrome (IBS) Consumption by Type
2.3.1 Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2013-2018)
2.3.2 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Type (2013-2018)
2.3.3 Global Irritable Bowel Syndrome (IBS) Sale Price by Type (2013-2018)
2.4 Irritable Bowel Syndrome (IBS) Segment by Application
2.4.1 Women
2.4.2 Men
2.5 Irritable Bowel Syndrome (IBS) Consumption by Application
2.5.1 Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Application (2013-2018)
2.5.2 Global Irritable Bowel Syndrome (IBS) Value and Market Share by Application (2013-2018)
2.5.3 Global Irritable Bowel Syndrome (IBS) Sale Price by Application (2013-2018)
3 GLOBAL IRRITABLE BOWEL SYNDROME (IBS) BY PLAYERS
3.1 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Players
3.1.1 Global Irritable Bowel Syndrome (IBS) Sales by Players (2016-2018)
3.1.2 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Players (2016-2018)
3.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players
3.2.1 Global Irritable Bowel Syndrome (IBS) Revenue by Players (2016-2018)
3.2.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players (2016-2018)
3.3 Global Irritable Bowel Syndrome (IBS) Sale Price by Players
3.4 Global Irritable Bowel Syndrome (IBS) Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Irritable Bowel Syndrome (IBS) Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Irritable Bowel Syndrome (IBS) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 IRRITABLE BOWEL SYNDROME (IBS) BY REGIONS
4.1 Irritable Bowel Syndrome (IBS) by Regions
4.1.1 Global Irritable Bowel Syndrome (IBS) Consumption by Regions
4.1.2 Global Irritable Bowel Syndrome (IBS) Value by Regions
4.2 Americas Irritable Bowel Syndrome (IBS) Consumption Growth
4.3 APAC Irritable Bowel Syndrome (IBS) Consumption Growth
4.4 Europe Irritable Bowel Syndrome (IBS) Consumption Growth
4.5 Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Growth
5 AMERICAS
5.1 Americas Irritable Bowel Syndrome (IBS) Consumption by Countries
5.1.1 Americas Irritable Bowel Syndrome (IBS) Consumption by Countries (2013-2018)
5.1.2 Americas Irritable Bowel Syndrome (IBS) Value by Countries (2013-2018)
5.2 Americas Irritable Bowel Syndrome (IBS) Consumption by Type
5.3 Americas Irritable Bowel Syndrome (IBS) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Irritable Bowel Syndrome (IBS) Consumption by Countries
6.1.1 APAC Irritable Bowel Syndrome (IBS) Consumption by Countries (2013-2018)
6.1.2 APAC Irritable Bowel Syndrome (IBS) Value by Countries (2013-2018)
6.2 APAC Irritable Bowel Syndrome (IBS) Consumption by Type
6.3 APAC Irritable Bowel Syndrome (IBS) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe Irritable Bowel Syndrome (IBS) by Countries
7.1.1 Europe Irritable Bowel Syndrome (IBS) Consumption by Countries (2013-2018)
7.1.2 Europe Irritable Bowel Syndrome (IBS) Value by Countries (2013-2018)
7.2 Europe Irritable Bowel Syndrome (IBS) Consumption by Type
7.3 Europe Irritable Bowel Syndrome (IBS) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Irritable Bowel Syndrome (IBS) by Countries
8.1.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Value by Countries (2013-2018)
8.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption by Type
8.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Irritable Bowel Syndrome (IBS) Distributors
10.3 Irritable Bowel Syndrome (IBS) Customer
11 GLOBAL IRRITABLE BOWEL SYNDROME (IBS) MARKET FORECAST
11.1 Global Irritable Bowel Syndrome (IBS) Consumption Forecast (2018-2023)
11.2 Global Irritable Bowel Syndrome (IBS) Forecast by Regions
11.2.1 Global Irritable Bowel Syndrome (IBS) Forecast by Regions (2018-2023)
11.2.2 Global Irritable Bowel Syndrome (IBS) Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Irritable Bowel Syndrome (IBS) Forecast by Type
11.8 Global Irritable Bowel Syndrome (IBS) Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 Allergan
12.1.1 Company Details
12.1.2 Irritable Bowel Syndrome (IBS) Product Offered
12.1.3 Allergan Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Allergan News
12.2 Valeant Pharmaceuticals
12.2.1 Company Details
12.2.2 Irritable Bowel Syndrome (IBS) Product Offered
12.2.3 Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Valeant Pharmaceuticals News
12.3 Takeda
12.3.1 Company Details
12.3.2 Irritable Bowel Syndrome (IBS) Product Offered
12.3.3 Takeda Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Takeda News
12.4 Sucampo Pharmaceuticals
12.4.1 Company Details
12.4.2 Irritable Bowel Syndrome (IBS) Product Offered
12.4.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Sucampo Pharmaceuticals News
12.5 McNeil Consumer Healthcare
12.5.1 Company Details
12.5.2 Irritable Bowel Syndrome (IBS) Product Offered
12.5.3 McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 McNeil Consumer Healthcare News
12.6 Sebela Pharmaceuticals
12.6.1 Company Details
12.6.2 Irritable Bowel Syndrome (IBS) Product Offered
12.6.3 Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Sebela Pharmaceuticals News
12.7 Astellas Pharmaceuticals
12.7.1 Company Details
12.7.2 Irritable Bowel Syndrome (IBS) Product Offered
12.7.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Astellas Pharmaceuticals News
12.8 IM HealthScience
12.8.1 Company Details
12.8.2 Irritable Bowel Syndrome (IBS) Product Offered
12.8.3 IM HealthScience Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 IM HealthScience News
13 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Irritable Bowel Syndrome (IBS) Consumption 2013-2023
2.1.2 Irritable Bowel Syndrome (IBS) Consumption CAGR by Region
2.2 Irritable Bowel Syndrome (IBS) Segment by Type
2.2.1 IBS-D Drug
2.2.2 IBS-C Drug
2.2.3 Other
2.3 Irritable Bowel Syndrome (IBS) Consumption by Type
2.3.1 Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2013-2018)
2.3.2 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Type (2013-2018)
2.3.3 Global Irritable Bowel Syndrome (IBS) Sale Price by Type (2013-2018)
2.4 Irritable Bowel Syndrome (IBS) Segment by Application
2.4.1 Women
2.4.2 Men
2.5 Irritable Bowel Syndrome (IBS) Consumption by Application
2.5.1 Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Application (2013-2018)
2.5.2 Global Irritable Bowel Syndrome (IBS) Value and Market Share by Application (2013-2018)
2.5.3 Global Irritable Bowel Syndrome (IBS) Sale Price by Application (2013-2018)
3 GLOBAL IRRITABLE BOWEL SYNDROME (IBS) BY PLAYERS
3.1 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Players
3.1.1 Global Irritable Bowel Syndrome (IBS) Sales by Players (2016-2018)
3.1.2 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Players (2016-2018)
3.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players
3.2.1 Global Irritable Bowel Syndrome (IBS) Revenue by Players (2016-2018)
3.2.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players (2016-2018)
3.3 Global Irritable Bowel Syndrome (IBS) Sale Price by Players
3.4 Global Irritable Bowel Syndrome (IBS) Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Irritable Bowel Syndrome (IBS) Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Irritable Bowel Syndrome (IBS) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 IRRITABLE BOWEL SYNDROME (IBS) BY REGIONS
4.1 Irritable Bowel Syndrome (IBS) by Regions
4.1.1 Global Irritable Bowel Syndrome (IBS) Consumption by Regions
4.1.2 Global Irritable Bowel Syndrome (IBS) Value by Regions
4.2 Americas Irritable Bowel Syndrome (IBS) Consumption Growth
4.3 APAC Irritable Bowel Syndrome (IBS) Consumption Growth
4.4 Europe Irritable Bowel Syndrome (IBS) Consumption Growth
4.5 Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Growth
5 AMERICAS
5.1 Americas Irritable Bowel Syndrome (IBS) Consumption by Countries
5.1.1 Americas Irritable Bowel Syndrome (IBS) Consumption by Countries (2013-2018)
5.1.2 Americas Irritable Bowel Syndrome (IBS) Value by Countries (2013-2018)
5.2 Americas Irritable Bowel Syndrome (IBS) Consumption by Type
5.3 Americas Irritable Bowel Syndrome (IBS) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Irritable Bowel Syndrome (IBS) Consumption by Countries
6.1.1 APAC Irritable Bowel Syndrome (IBS) Consumption by Countries (2013-2018)
6.1.2 APAC Irritable Bowel Syndrome (IBS) Value by Countries (2013-2018)
6.2 APAC Irritable Bowel Syndrome (IBS) Consumption by Type
6.3 APAC Irritable Bowel Syndrome (IBS) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe Irritable Bowel Syndrome (IBS) by Countries
7.1.1 Europe Irritable Bowel Syndrome (IBS) Consumption by Countries (2013-2018)
7.1.2 Europe Irritable Bowel Syndrome (IBS) Value by Countries (2013-2018)
7.2 Europe Irritable Bowel Syndrome (IBS) Consumption by Type
7.3 Europe Irritable Bowel Syndrome (IBS) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Irritable Bowel Syndrome (IBS) by Countries
8.1.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Value by Countries (2013-2018)
8.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption by Type
8.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Irritable Bowel Syndrome (IBS) Distributors
10.3 Irritable Bowel Syndrome (IBS) Customer
11 GLOBAL IRRITABLE BOWEL SYNDROME (IBS) MARKET FORECAST
11.1 Global Irritable Bowel Syndrome (IBS) Consumption Forecast (2018-2023)
11.2 Global Irritable Bowel Syndrome (IBS) Forecast by Regions
11.2.1 Global Irritable Bowel Syndrome (IBS) Forecast by Regions (2018-2023)
11.2.2 Global Irritable Bowel Syndrome (IBS) Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Irritable Bowel Syndrome (IBS) Forecast by Type
11.8 Global Irritable Bowel Syndrome (IBS) Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 Allergan
12.1.1 Company Details
12.1.2 Irritable Bowel Syndrome (IBS) Product Offered
12.1.3 Allergan Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Allergan News
12.2 Valeant Pharmaceuticals
12.2.1 Company Details
12.2.2 Irritable Bowel Syndrome (IBS) Product Offered
12.2.3 Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Valeant Pharmaceuticals News
12.3 Takeda
12.3.1 Company Details
12.3.2 Irritable Bowel Syndrome (IBS) Product Offered
12.3.3 Takeda Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Takeda News
12.4 Sucampo Pharmaceuticals
12.4.1 Company Details
12.4.2 Irritable Bowel Syndrome (IBS) Product Offered
12.4.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Sucampo Pharmaceuticals News
12.5 McNeil Consumer Healthcare
12.5.1 Company Details
12.5.2 Irritable Bowel Syndrome (IBS) Product Offered
12.5.3 McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 McNeil Consumer Healthcare News
12.6 Sebela Pharmaceuticals
12.6.1 Company Details
12.6.2 Irritable Bowel Syndrome (IBS) Product Offered
12.6.3 Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Sebela Pharmaceuticals News
12.7 Astellas Pharmaceuticals
12.7.1 Company Details
12.7.2 Irritable Bowel Syndrome (IBS) Product Offered
12.7.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Astellas Pharmaceuticals News
12.8 IM HealthScience
12.8.1 Company Details
12.8.2 Irritable Bowel Syndrome (IBS) Product Offered
12.8.3 IM HealthScience Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 IM HealthScience News
13 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES
Figure Picture of Irritable Bowel Syndrome (IBS)
Table Product Specifications of Irritable Bowel Syndrome (IBS)
Figure Irritable Bowel Syndrome (IBS) Report Years Considered
Figure Market Research Methodology
Figure Global Irritable Bowel Syndrome (IBS) Consumption Growth Rate 2013-2023 (K Units)
Figure Global Irritable Bowel Syndrome (IBS) Value Growth Rate 2013-2023 ($ Millions)
Table Irritable Bowel Syndrome (IBS) Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of IBS-D Drug
Table Major Players of IBS-D Drug
Figure Product Picture of IBS-C Drug
Table Major Players of IBS-C Drug
Figure Product Picture of Other
Table Major Players of Other
Table Global Consumption Sales by Type (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2013-2018)
Figure Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Revenue by Type (2013-2018) ($ million)
Table Global Irritable Bowel Syndrome (IBS) Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Irritable Bowel Syndrome (IBS) Value Market Share by Type (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Sale Price by Type (2013-2018)
Figure Irritable Bowel Syndrome (IBS) Consumed in Women
Figure Global Irritable Bowel Syndrome (IBS) Market: Women (2013-2018) (K Units)
Figure Global Irritable Bowel Syndrome (IBS) Market: Women (2013-2018) ($ Millions)
Figure Global Women YoY Growth ($ Millions)
Figure Irritable Bowel Syndrome (IBS) Consumed in Men
Figure Global Irritable Bowel Syndrome (IBS) Market: Men (2013-2018) (K Units)
Figure Global Irritable Bowel Syndrome (IBS) Market: Men (2013-2018) ($ Millions)
Figure Global Men YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Application (2013-2018)
Figure Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Application (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Value by Application (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Value Market Share by Application (2013-2018)
Figure Global Irritable Bowel Syndrome (IBS) Value Market Share by Application (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Sale Price by Application (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Sales by Players (2016-2018) (K Units)
Table Global Irritable Bowel Syndrome (IBS) Sales Market Share by Players (2016-2018)
Figure Global Irritable Bowel Syndrome (IBS) Sales Market Share by Players in 2016
Figure Global Irritable Bowel Syndrome (IBS) Sales Market Share by Players in 2017
Table Global Irritable Bowel Syndrome (IBS) Revenue by Players (2016-2018) ($ Millions)
Table Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players (2016-2018)
Figure Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players in 2016
Figure Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players in 2017
Table Global Irritable Bowel Syndrome (IBS) Sale Price by Players (2016-2018)
Figure Global Irritable Bowel Syndrome (IBS) Sale Price by Players in 2017
Table Global Irritable Bowel Syndrome (IBS) Manufacturing Base Distribution and Sales Area by Players
Table Players Irritable Bowel Syndrome (IBS) Products Offered
Table Irritable Bowel Syndrome (IBS) Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Irritable Bowel Syndrome (IBS) Consumption by Regions 2013-2018 (K Units)
Table Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Regions 2013-2018
Figure Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Regions 2013-2018
Table Global Irritable Bowel Syndrome (IBS) Value by Regions 2013-2018 ($ Millions)
Table Global Irritable Bowel Syndrome (IBS) Value Market Share by Regions 2013-2018
Figure Global Irritable Bowel Syndrome (IBS) Value Market Share by Regions 2013-2018
Figure Americas Irritable Bowel Syndrome (IBS) Consumption 2013-2018 (K Units)
Figure Americas Irritable Bowel Syndrome (IBS) Value 2013-2018 ($ Millions)
Figure APAC Irritable Bowel Syndrome (IBS) Consumption 2013-2018 (K Units)
Figure APAC Irritable Bowel Syndrome (IBS) Value 2013-2018 ($ Millions)
Figure Europe Irritable Bowel Syndrome (IBS) Consumption 2013-2018 (K Units)
Figure Europe Irritable Bowel Syndrome (IBS) Value 2013-2018 ($ Millions)
Figure Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption 2013-2018 (K Units)
Figure Middle East & Africa Irritable Bowel Syndrome (IBS) Value 2013-2018 ($ Millions)
Table Americas Irritable Bowel Syndrome (IBS) Consumption by Countries (2013-2018) (K Units)
Table Americas Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries (2013-2018)
Figure Americas Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries in 2017
Table Americas Irritable Bowel Syndrome (IBS) Value by Countries (2013-2018) ($ Millions)
Table Americas Irritable Bowel Syndrome (IBS) Value Market Share by Countries (2013-2018)
Figure Americas Irritable Bowel Syndrome (IBS) Value Market Share by Countries in 2017
Table Americas Irritable Bowel Syndrome (IBS) Consumption by Type (2013-2018) (K Units)
Table Americas Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2013-2018)
Figure Americas Irritable Bowel Syndrome (IBS) Consumption Market Share by Type in 2017
Table Americas Irritable Bowel Syndrome (IBS) Consumption by Application (2013-2018) (K Units)
Table Americas Irritable Bowel Syndrome (IBS) Consumption Market Share by Application (2013-2018)
Figure Americas Irritable Bowel Syndrome (IBS) Consumption Market Share by Application in 2017
Figure United States Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure United States Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Canada Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Canada Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Mexico Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Mexico Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Table APAC Irritable Bowel Syndrome (IBS) Consumption by Countries (2013-2018) (K Units)
Table APAC Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries (2013-2018)
Figure APAC Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries in 2017
Table APAC Irritable Bowel Syndrome (IBS) Value by Countries (2013-2018) ($ Millions)
Table APAC Irritable Bowel Syndrome (IBS) Value Market Share by Countries (2013-2018)
Figure APAC Irritable Bowel Syndrome (IBS) Value Market Share by Countries in 2017
Table APAC Irritable Bowel Syndrome (IBS) Consumption by Type (2013-2018) (K Units)
Table APAC Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2013-2018)
Figure APAC Irritable Bowel Syndrome (IBS) Consumption Market Share by Type in 2017
Table APAC Irritable Bowel Syndrome (IBS) Consumption by Application (2013-2018) (K Units)
Table APAC Irritable Bowel Syndrome (IBS) Consumption Market Share by Application (2013-2018)
Figure APAC Irritable Bowel Syndrome (IBS) Consumption Market Share by Application in 2017
Figure China Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure China Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Japan Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Japan Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Korea Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Korea Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure India Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure India Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Australia Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Australia Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Table Europe Irritable Bowel Syndrome (IBS) Consumption by Countries (2013-2018) (K Units)
Table Europe Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries (2013-2018)
Figure Europe Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries in 2017
Table Europe Irritable Bowel Syndrome (IBS) Value by Countries (2013-2018) ($ Millions)
Table Europe Irritable Bowel Syndrome (IBS) Value Market Share by Countries (2013-2018)
Figure Europe Irritable Bowel Syndrome (IBS) Value Market Share by Countries in 2017
Table Europe Irritable Bowel Syndrome (IBS) Consumption by Type (2013-2018) (K Units)
Table Europe Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2013-2018)
Figure Europe Irritable Bowel Syndrome (IBS) Consumption Market Share by Type in 2017
Table Europe Irritable Bowel Syndrome (IBS) Consumption by Application (2013-2018) (K Units)
Table Europe Irritable Bowel Syndrome (IBS) Consumption Market Share by Application (2013-2018)
Figure Europe Irritable Bowel Syndrome (IBS) Consumption Market Share by Application in 2017
Figure Germany Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Germany Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure France Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure France Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure UK Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure UK Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Italy Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Italy Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Russia Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Russia Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Spain Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Spain Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries in 2017
Table Middle East & Africa Irritable Bowel Syndrome (IBS) Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Irritable Bowel Syndrome (IBS) Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Irritable Bowel Syndrome (IBS) Value Market Share by Countries in 2017
Table Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Market Share by Type in 2017
Table Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Market Share by Application in 2017
Figure Egypt Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Egypt Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure South Africa Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure South Africa Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Israel Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Israel Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Turkey Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Turkey Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Table Irritable Bowel Syndrome (IBS) Distributors List
Table Irritable Bowel Syndrome (IBS) Customer List
Figure Global Irritable Bowel Syndrome (IBS) Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Irritable Bowel Syndrome (IBS) Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Irritable Bowel Syndrome (IBS) Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Irritable Bowel Syndrome (IBS) Consumption Market Forecast by Regions
Table Global Irritable Bowel Syndrome (IBS) Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Irritable Bowel Syndrome (IBS) Value Market Share Forecast by Regions
Figure Americas Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Americas Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure APAC Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure APAC Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Europe Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Europe Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Middle East & Africa Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure United States Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure United States Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Canada Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Canada Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Mexico Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Mexico Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Brazil Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Brazil Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure China Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure China Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Japan Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Japan Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Korea Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Korea Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Southeast Asia Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Southeast Asia Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure India Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure India Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Australia Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Australia Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Germany Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Germany Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure France Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure France Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure UK Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure UK Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Italy Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Italy Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Russia Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Russia Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Spain Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Spain Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Egypt Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Egypt Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure South Africa Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure South Africa Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Israel Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Israel Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Turkey Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Turkey Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure GCC Countries Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure GCC Countries Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Table Global Irritable Bowel Syndrome (IBS) Consumption Forecast by Type (2018-2023) (K Units)
Table Global Irritable Bowel Syndrome (IBS) Consumption Market Share Forecast by Type (2018-2023)
Table Global Irritable Bowel Syndrome (IBS) Value Forecast by Type (2018-2023) ($ Millions)
Table Global Irritable Bowel Syndrome (IBS) Value Market Share Forecast by Type (2018-2023)
Table Global Irritable Bowel Syndrome (IBS) Consumption Forecast by Application (2018-2023) (K Units)
Table Global Irritable Bowel Syndrome (IBS) Consumption Market Share Forecast by Application (2018-2023)
Table Global Irritable Bowel Syndrome (IBS) Value Forecast by Application (2018-2023) ($ Millions)
Table Global Irritable Bowel Syndrome (IBS) Value Market Share Forecast by Application (2018-2023)
Table Allergan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Allergan Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Allergan Irritable Bowel Syndrome (IBS) Market Share (2016-2018)
Table Valeant Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Market Share (2016-2018)
Table Takeda Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Takeda Irritable Bowel Syndrome (IBS) Market Share (2016-2018)
Table Sucampo Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Market Share (2016-2018)
Table McNeil Consumer Healthcare Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Market Share (2016-2018)
Table Sebela Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Market Share (2016-2018)
Table Astellas Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Market Share (2016-2018)
Table IM HealthScience Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table IM HealthScience Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure IM HealthScience Irritable Bowel Syndrome (IBS) Market Share (2016-2018)
Figure Picture of Irritable Bowel Syndrome (IBS)
Table Product Specifications of Irritable Bowel Syndrome (IBS)
Figure Irritable Bowel Syndrome (IBS) Report Years Considered
Figure Market Research Methodology
Figure Global Irritable Bowel Syndrome (IBS) Consumption Growth Rate 2013-2023 (K Units)
Figure Global Irritable Bowel Syndrome (IBS) Value Growth Rate 2013-2023 ($ Millions)
Table Irritable Bowel Syndrome (IBS) Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of IBS-D Drug
Table Major Players of IBS-D Drug
Figure Product Picture of IBS-C Drug
Table Major Players of IBS-C Drug
Figure Product Picture of Other
Table Major Players of Other
Table Global Consumption Sales by Type (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2013-2018)
Figure Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Revenue by Type (2013-2018) ($ million)
Table Global Irritable Bowel Syndrome (IBS) Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Irritable Bowel Syndrome (IBS) Value Market Share by Type (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Sale Price by Type (2013-2018)
Figure Irritable Bowel Syndrome (IBS) Consumed in Women
Figure Global Irritable Bowel Syndrome (IBS) Market: Women (2013-2018) (K Units)
Figure Global Irritable Bowel Syndrome (IBS) Market: Women (2013-2018) ($ Millions)
Figure Global Women YoY Growth ($ Millions)
Figure Irritable Bowel Syndrome (IBS) Consumed in Men
Figure Global Irritable Bowel Syndrome (IBS) Market: Men (2013-2018) (K Units)
Figure Global Irritable Bowel Syndrome (IBS) Market: Men (2013-2018) ($ Millions)
Figure Global Men YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Application (2013-2018)
Figure Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Application (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Value by Application (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Value Market Share by Application (2013-2018)
Figure Global Irritable Bowel Syndrome (IBS) Value Market Share by Application (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Sale Price by Application (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Sales by Players (2016-2018) (K Units)
Table Global Irritable Bowel Syndrome (IBS) Sales Market Share by Players (2016-2018)
Figure Global Irritable Bowel Syndrome (IBS) Sales Market Share by Players in 2016
Figure Global Irritable Bowel Syndrome (IBS) Sales Market Share by Players in 2017
Table Global Irritable Bowel Syndrome (IBS) Revenue by Players (2016-2018) ($ Millions)
Table Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players (2016-2018)
Figure Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players in 2016
Figure Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players in 2017
Table Global Irritable Bowel Syndrome (IBS) Sale Price by Players (2016-2018)
Figure Global Irritable Bowel Syndrome (IBS) Sale Price by Players in 2017
Table Global Irritable Bowel Syndrome (IBS) Manufacturing Base Distribution and Sales Area by Players
Table Players Irritable Bowel Syndrome (IBS) Products Offered
Table Irritable Bowel Syndrome (IBS) Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Irritable Bowel Syndrome (IBS) Consumption by Regions 2013-2018 (K Units)
Table Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Regions 2013-2018
Figure Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Regions 2013-2018
Table Global Irritable Bowel Syndrome (IBS) Value by Regions 2013-2018 ($ Millions)
Table Global Irritable Bowel Syndrome (IBS) Value Market Share by Regions 2013-2018
Figure Global Irritable Bowel Syndrome (IBS) Value Market Share by Regions 2013-2018
Figure Americas Irritable Bowel Syndrome (IBS) Consumption 2013-2018 (K Units)
Figure Americas Irritable Bowel Syndrome (IBS) Value 2013-2018 ($ Millions)
Figure APAC Irritable Bowel Syndrome (IBS) Consumption 2013-2018 (K Units)
Figure APAC Irritable Bowel Syndrome (IBS) Value 2013-2018 ($ Millions)
Figure Europe Irritable Bowel Syndrome (IBS) Consumption 2013-2018 (K Units)
Figure Europe Irritable Bowel Syndrome (IBS) Value 2013-2018 ($ Millions)
Figure Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption 2013-2018 (K Units)
Figure Middle East & Africa Irritable Bowel Syndrome (IBS) Value 2013-2018 ($ Millions)
Table Americas Irritable Bowel Syndrome (IBS) Consumption by Countries (2013-2018) (K Units)
Table Americas Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries (2013-2018)
Figure Americas Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries in 2017
Table Americas Irritable Bowel Syndrome (IBS) Value by Countries (2013-2018) ($ Millions)
Table Americas Irritable Bowel Syndrome (IBS) Value Market Share by Countries (2013-2018)
Figure Americas Irritable Bowel Syndrome (IBS) Value Market Share by Countries in 2017
Table Americas Irritable Bowel Syndrome (IBS) Consumption by Type (2013-2018) (K Units)
Table Americas Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2013-2018)
Figure Americas Irritable Bowel Syndrome (IBS) Consumption Market Share by Type in 2017
Table Americas Irritable Bowel Syndrome (IBS) Consumption by Application (2013-2018) (K Units)
Table Americas Irritable Bowel Syndrome (IBS) Consumption Market Share by Application (2013-2018)
Figure Americas Irritable Bowel Syndrome (IBS) Consumption Market Share by Application in 2017
Figure United States Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure United States Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Canada Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Canada Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Mexico Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Mexico Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Table APAC Irritable Bowel Syndrome (IBS) Consumption by Countries (2013-2018) (K Units)
Table APAC Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries (2013-2018)
Figure APAC Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries in 2017
Table APAC Irritable Bowel Syndrome (IBS) Value by Countries (2013-2018) ($ Millions)
Table APAC Irritable Bowel Syndrome (IBS) Value Market Share by Countries (2013-2018)
Figure APAC Irritable Bowel Syndrome (IBS) Value Market Share by Countries in 2017
Table APAC Irritable Bowel Syndrome (IBS) Consumption by Type (2013-2018) (K Units)
Table APAC Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2013-2018)
Figure APAC Irritable Bowel Syndrome (IBS) Consumption Market Share by Type in 2017
Table APAC Irritable Bowel Syndrome (IBS) Consumption by Application (2013-2018) (K Units)
Table APAC Irritable Bowel Syndrome (IBS) Consumption Market Share by Application (2013-2018)
Figure APAC Irritable Bowel Syndrome (IBS) Consumption Market Share by Application in 2017
Figure China Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure China Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Japan Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Japan Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Korea Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Korea Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure India Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure India Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Australia Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Australia Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Table Europe Irritable Bowel Syndrome (IBS) Consumption by Countries (2013-2018) (K Units)
Table Europe Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries (2013-2018)
Figure Europe Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries in 2017
Table Europe Irritable Bowel Syndrome (IBS) Value by Countries (2013-2018) ($ Millions)
Table Europe Irritable Bowel Syndrome (IBS) Value Market Share by Countries (2013-2018)
Figure Europe Irritable Bowel Syndrome (IBS) Value Market Share by Countries in 2017
Table Europe Irritable Bowel Syndrome (IBS) Consumption by Type (2013-2018) (K Units)
Table Europe Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2013-2018)
Figure Europe Irritable Bowel Syndrome (IBS) Consumption Market Share by Type in 2017
Table Europe Irritable Bowel Syndrome (IBS) Consumption by Application (2013-2018) (K Units)
Table Europe Irritable Bowel Syndrome (IBS) Consumption Market Share by Application (2013-2018)
Figure Europe Irritable Bowel Syndrome (IBS) Consumption Market Share by Application in 2017
Figure Germany Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Germany Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure France Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure France Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure UK Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure UK Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Italy Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Italy Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Russia Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Russia Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Spain Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Spain Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries in 2017
Table Middle East & Africa Irritable Bowel Syndrome (IBS) Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Irritable Bowel Syndrome (IBS) Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Irritable Bowel Syndrome (IBS) Value Market Share by Countries in 2017
Table Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Market Share by Type in 2017
Table Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Market Share by Application in 2017
Figure Egypt Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Egypt Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure South Africa Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure South Africa Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Israel Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Israel Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure Turkey Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure Turkey Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Irritable Bowel Syndrome (IBS) Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Irritable Bowel Syndrome (IBS) Value Growth 2013-2018 ($ Millions)
Table Irritable Bowel Syndrome (IBS) Distributors List
Table Irritable Bowel Syndrome (IBS) Customer List
Figure Global Irritable Bowel Syndrome (IBS) Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Irritable Bowel Syndrome (IBS) Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Irritable Bowel Syndrome (IBS) Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Irritable Bowel Syndrome (IBS) Consumption Market Forecast by Regions
Table Global Irritable Bowel Syndrome (IBS) Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Irritable Bowel Syndrome (IBS) Value Market Share Forecast by Regions
Figure Americas Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Americas Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure APAC Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure APAC Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Europe Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Europe Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Middle East & Africa Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure United States Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure United States Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Canada Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Canada Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Mexico Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Mexico Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Brazil Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Brazil Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure China Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure China Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Japan Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Japan Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Korea Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Korea Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Southeast Asia Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Southeast Asia Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure India Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure India Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Australia Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Australia Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Germany Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Germany Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure France Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure France Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure UK Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure UK Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Italy Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Italy Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Russia Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Russia Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Spain Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Spain Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Egypt Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Egypt Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure South Africa Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure South Africa Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Israel Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Israel Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure Turkey Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure Turkey Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Figure GCC Countries Irritable Bowel Syndrome (IBS) Consumption 2018-2023 (K Units)
Figure GCC Countries Irritable Bowel Syndrome (IBS) Value 2018-2023 ($ Millions)
Table Global Irritable Bowel Syndrome (IBS) Consumption Forecast by Type (2018-2023) (K Units)
Table Global Irritable Bowel Syndrome (IBS) Consumption Market Share Forecast by Type (2018-2023)
Table Global Irritable Bowel Syndrome (IBS) Value Forecast by Type (2018-2023) ($ Millions)
Table Global Irritable Bowel Syndrome (IBS) Value Market Share Forecast by Type (2018-2023)
Table Global Irritable Bowel Syndrome (IBS) Consumption Forecast by Application (2018-2023) (K Units)
Table Global Irritable Bowel Syndrome (IBS) Consumption Market Share Forecast by Application (2018-2023)
Table Global Irritable Bowel Syndrome (IBS) Value Forecast by Application (2018-2023) ($ Millions)
Table Global Irritable Bowel Syndrome (IBS) Value Market Share Forecast by Application (2018-2023)
Table Allergan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Allergan Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Allergan Irritable Bowel Syndrome (IBS) Market Share (2016-2018)
Table Valeant Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Market Share (2016-2018)
Table Takeda Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Takeda Irritable Bowel Syndrome (IBS) Market Share (2016-2018)
Table Sucampo Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Market Share (2016-2018)
Table McNeil Consumer Healthcare Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Market Share (2016-2018)
Table Sebela Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Market Share (2016-2018)
Table Astellas Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Market Share (2016-2018)
Table IM HealthScience Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table IM HealthScience Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2016-2018)
Figure IM HealthScience Irritable Bowel Syndrome (IBS) Market Share (2016-2018)
